AIM2 and hepatocellular carcinoma: Further investigation revealed that exogenous overexpression of AIM2 in HCC cells exerted inhibitory effects on the mammalian target of rapamycin (mTOR)-S6K1 signaling pathway, a critical axis implicated in cellular proliferation, survival, and metabolism (54).